Concepedia

Yvonne Westermaier

YW

9

Publications

338

Citations

9

H-Index

2011

Active since

Affiliations

University of Geneva(Current)

Universitat de Barcelona

University of Lausanne

University Hospital of Geneva

Boehringer Ingelheim (Austria)

Yvonne Westermaier is an author at University of Geneva specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2011–2024

9

Publications

9

NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action

Vincent Jaquet, Julien Marcoux, Éric Forest et al. · British Journal of Pharmacology · 2011 · 115 citations · Full text

Virtual screening: An in silico tool for interlacing the chemical universe with the proteome

Yvonne Westermaier, Xavier Barril, Léonardo Scapozza · Methods · 2014 · 64 citations

, , +14

Binding mode prediction and MD/MMPBSA-based free energy ranking for agonists of REV-ERBα/NCoR

Yvonne Westermaier, Sergio Ruiz‐Carmona, Isabelle Théret et al. · Journal of Computer-Aided Molecular Design · 2017 · 43 citations

, , +7

Confounding Factors in Targeted Degradation of Short-Lived Proteins

Vesna Vetma, Laura Casares Perez, J. E. Elias et al. · ACS Chemical Biology · 2024 · 41 citations · Full text

, , +17

Extensive benchmark of rDock as a peptide-protein docking tool

Daniel Soler, Yvonne Westermaier, Robert Soliva · Journal of Computer-Aided Molecular Design · 2019 · 19 citations

, , +6

Rows per page

1–5 of 9